Search

Your search keyword '"Yu Katagiri"' showing total 91 results

Search Constraints

Start Over You searched for: Author "Yu Katagiri" Remove constraint Author: "Yu Katagiri"
91 results on '"Yu Katagiri"'

Search Results

1. Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer

2. Palliative radiotherapy for gastric cancer bleeding: a multi-institutional retrospective study

3. Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice

4. Feasibility of Differential Dose—Volume Histogram Features in Multivariate Prediction Model for Radiation Pneumonitis Occurrence

5. Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer.

7. Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer

8. Stereotactic Radiosurgery for Lung Cancer with a Risk-Adapted Strategy Using the Volumetric Modulated Arc Therapy Technique: A Single Arm Phase II Study

9. Differences in patterns of recurrence of squamous cell carcinoma and adenocarcinoma after radiotherapy for stage III non-small cell lung cancer

10. Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castrationresistant prostate cancer.

11. Hypofractionated Radiotherapy for Anaplastic Thyroid Carcinoma: 15 Years of Experience in a Single Institution

12. Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images

14. On $p$-adic entropy of some solenoid dynamical systems

15. PO-1003: Preliminary results of SRS for a lung tumor: a single-arm phase 2 study in a single institute

16. Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid Carcinoma

17. Stereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review

18. Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis

19. Texture Analysis of FDG-PET/CT for Patients with Esophageal SCC Treated By Chemoradiotherapy

20. Hypofractionated Radiation Therapy for Anaplastic Thyroid Carcinoma: 15 Years of Experience in a Single Institution

21. Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer

22. Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma

23. Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study

24. Chemoradiotherapy for T4 and/or M1 lymph node esophageal cancer: experience since 2000 at a high-volume center in Japan

25. Evaluation of Prognostic Factors in Clinical Blood Examinations in Patients Undergoing Chemoradiation Therapy for Stage II-III Thoracic Esophageal Cancer

26. Clinical Factors Relating to Cervical Body Volume Reduction during Curative External Beam Radiation Therapy for Head and Neck Cancer

27. Metabolic Tumor Volume and Total Lesion Glycolysis on FDG-PET/CT Are Possible Prognostic Factors for Stage I Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy

28. EP-1195: Chemoradiotherapy for T4 and/or M1 lymph esophageal cancer - recent experience in a Japanese high-volume center

29. Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma.

30. Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocols.

31. Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy.

33. Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocols

34. Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy

35. Aureobasidium pullulans culture supernatant significantly stimulates R-848-activated phagocytosis of PMA-induced THP-1 macrophages.

36. The human CD10 lacking an N-glycan at Asn(628) is deficient in surface expression and neutral endopeptidase activity.

37. Lipid rafts enriched in monosialylGb5Cer carrying the stage-specific embryonic antigen-4 epitope are involved in development of mouse preimplantation embryos at cleavage stage.

38. GalNAcβ1,3-linked paragloboside carries the epitope of a sperm maturation-related glycoprotein that is recognized by the monoclonal antibody MC121.

39. Accelerated biosynthesis of neolacto-series glycosphingolipids in differentiated mouse embryonal carcinoma F9 cells detected by using dodecyl N-acetylglucosaminide as a saccharide primer.

40. A microfabricated scaffold induces the spheroid formation of human bone marrow-derived mesenchymal progenitor cells and promotes efficient adipogenic differentiation.

41. Neuroblastoma cells can be classified according to glycosphingolipid expression profiles identified by liquid chromatography-tandem mass spectrometry.

42. Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma.

43. Ex vivo expanded cord blood CD4 T lymphocytes exhibit a distinct expression profile of cytokine-related genes from those of peripheral blood origin.

44. The expression of granulysin in systemic anaplastic large cell lymphoma in childhood.

45. Kinetics and effect of integrin expression on human CD34(+) cells during murine leukemia virus-derived retroviral transduction with recombinant fibronectin for stem cell gene therapy.

46. EWS/ETS regulates the expression of the Dickkopf family in Ewing family tumor cells.

47. B-cell-activating factor inhibits CD20-mediated and B-cell receptor-mediated apoptosis in human B cells.

48. The detergent-insoluble microdomains, rafts, can be used as an effective immunogen.

49. Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells.

50. Human osteoblasts support hematopoietic cell development in vitro.

Catalog

Books, media, physical & digital resources